BiotechTube
Home/HepQuant/Dr. Greg Everson
DG

Dr. Greg Everson

Prominent Clinical Spokesperson / Likely Scientific/Medical Leader

HepQuant

Therapeutic Areas

Liver DiseaseCirrhosisMASH (Metabolic dysfunction-associated steatohepatitis)Portal Hypertension

HepQuant Pipeline

DrugIndicationPhase
HepQuant DuO Clinical TestChronic Liver Disease, Cirrhosis, MASH, PSCCommercial
Pharma Solutions / Clinical Trial EndpointLiver Disease Drug DevelopmentCommercial/Service